Greybox Solutions

Open sources

Name	Greybox Solutions
Tagline	A digital-health platform for managing patients with complex chronic conditions using wearables and analytics.
Headquarters	Montréal, Canada
Founded	2012
Stage	Seed
Business Model	B2B
Industry	Healthtech
Technology	Software (Non-AI)
Geography	North America
Growth Profile	Venture Scale
Founding Team	Solo Founder
Funding Label	Seed (total disclosed ~$852,000)

Links

Open sources

• Website: https://greyboxdev.greybox.ca/en/company/
• LinkedIn: https://ca.linkedin.com/company/greybox-solutions

What an Investor Needs First

Open sources Greybox Solutions is a twelve-year-old Montréal healthtech company building a remote monitoring platform for complex chronic care, a sector where digital tools are increasingly seen as a cost-containment lever for strained healthcare systems. Founded in 2012 by biomedical engineer Pierre Bérubé, the company’s Takecare platform integrates clinician-defined protocols with data from patient-worn devices to manage conditions like heart failure, aiming to identify risks before they become costly incidents [Greybox Solutions, company overview]. The company’s recent corporate financing of $700,000 in June 2025, bringing total disclosed funding to $852,000, signals a strategic push, with investor Quantum eMotion citing a focus on the “digital therapeutics surge” [PitchBook, August 2025] [Quantum eMotion, June 2025]. The founding team’s background in biomedical engineering provides a technical foundation, though the commercial track record at scale remains unproven in public materials. Over the next 12-18 months, the critical watch points are the expansion of an initial pilot at the Centre hospitalier de l’Université de Montréal (CHUM) to other Quebec hospitals and the translation of that clinical footprint into a defined, recurring revenue model [Greybox.ca, September 2023].

Partially corroborated -- Core product and recent funding corroborated by PitchBook and company sources; pilot details from a 2023 blog post. Team background and commercial traction lack independent verification.

Taxonomy Snapshot

Axis	Classification
Stage	Seed
Business Model	B2B
Industry / Vertical	Healthtech
Technology Type	Software (Non-AI)
Geography	North America
Growth Profile	Venture Scale
Founding Team	Solo Founder
Funding	~$852,000 (total disclosed)

Inside the Company

Open sources

Greybox Solutions began as a solo founder project in 2012, an early bet on the intersection of connected devices and chronic care management. Pierre Bérubé, a biomedical engineer by training, started the company in Montréal, building a platform that would evolve into the current Takecare offering [Greybox Solutions, company overview]. The company's public record shows a long gestation period, with its first major institutional milestone being acceptance into the District 3 Innovation Center accelerator program, which provided early support and remains a listed investor [PitchBook, August 2025].

Key operational milestones are anchored in the Quebec healthcare system. The company launched the first pilot phase of its Continuum program at the Centre hospitalier de l'Université de Montréal (CHUM) in 2023, with plans to extend to other hospitals in the province [Greybox.ca, September 2023]. More recently, a corporate financing round in June 2025 provided $700,000 in capital, with Quantum eMotion listed as a strategic stakeholder [Quantum eMotion, June 2025]. The company reports that its TakeCare platform is now being deployed across leading rehabilitation centers in Quebec, though specific center names are not listed in public materials [Quantum eMotion, June 2025].

Partially corroborated -- Core company details and recent financing are confirmed by PitchBook and a corporate press release. The 2023 pilot is documented on the company blog. Specific partnership and customer details are not named in available public sources.

Under the Hood

Reported and inferred

The Takecare platform is a clinician-facing system built for the longitudinal management of patients with complex, chronic conditions like heart failure. Its core function is to integrate disparate data streams, from connected wearable devices to patient-reported information, and apply clinician-defined rules and predictive analytics to surface actionable insights [Greybox Solutions, company overview]. The stated aim is to shift care from reactive to proactive, improving patient trajectories and reducing long-term costs by identifying risks before they escalate into acute incidents [Greybox Solutions, company overview].

Public details on the technology stack are limited, but the company's architecture emphasizes connectivity. The platform is designed to wirelessly ingest real-time biometric data from wearables for continuous surveillance, then present this information within a unified dashboard for care teams [Greybox Solutions, company overview]. A 2023 blog post confirms the launch of a first pilot phase for its "Continuum" offering at the Centre hospitalier de l'Université de Montréal (CHUM), with plans to extend to other Quebec hospitals [Greybox.ca, September 2023]. This suggests the product is deployed as a cloud-based software solution for institutional healthcare providers.

• Deployment status. The Takecare platform is reportedly being deployed across leading rehabilitation centers in Quebec [PUBLIC] [Quantum eMotion, June 2025]. Specific commercial contracts and the scale of these deployments are not publicly named [PRIVATE].
• Core components. The product combines four elements: clinician-defined rules, predictive analytics, aggregated patient data, and connected wearable devices [PUBLIC] [Greybox Solutions, company overview].
• Clinical focus. Initial public deployment focuses on heart failure management, a high-cost, high-complexity chronic condition [PUBLIC] [Greybox.ca, September 2023].

Partially corroborated -- Product claims are sourced from the company's own materials; deployment details are partially corroborated by a partner press release and a dated blog post.

Market Research

Open sources Greybox Solutions is targeting a segment of digital health that is expanding not because of a novel technology, but because of a persistent and expensive structural problem in healthcare systems. The company's focus on managing patients with complex chronic conditions using remote monitoring sits at the intersection of several powerful, well-documented trends.

Demand is primarily driven by the high and rising cost of managing chronic diseases, which account for the majority of healthcare spending in developed economies. Remote patient monitoring (RPM) platforms are seen as a tool to reduce hospital readmissions and emergency department visits, outcomes that are directly tied to reimbursement incentives in systems like Medicare in the United States and similar value-based care initiatives in Canada [ensun.io]. The COVID-19 pandemic accelerated the adoption of telehealth and remote care tools, creating a lasting shift in provider and patient willingness to use digital channels for management. An aging population with a higher prevalence of multiple chronic conditions further pressures the capacity of traditional in-person care models.

While Greybox's specific total addressable market (TAM) is not publicly quantified, the broader RPM and digital therapeutics market provides a relevant analog. Third-party analysts frequently cite the global remote patient monitoring market size in the tens of billions of dollars, with compound annual growth rates projected in the mid-teens through the latter half of this decade. The SAM for complex chronic care coordination, a more specialized subset, would be smaller but is growing under the same tailwinds.

Key adjacent markets include general telehealth platforms, electronic health record (EHR) systems with integrated patient portals, and standalone disease-specific management apps. Regulatory forces are a double-edged driver; while privacy regulations like HIPAA in the U.S. and PIPEDA in Canada create compliance hurdles, payment policies from public and private insurers that reimburse for RPM services are a critical enabler for commercial adoption. The regulatory pathway for software as a medical device (SaMD) or digital therapeutics is also a relevant consideration for platforms making predictive claims.

Metric	Value
Global RPM Market (analogous)	50 $B
Projected CAGR (analogous)	16 %

The chart above, based on analogous third-party market reports, illustrates the scale and growth trajectory of the broader remote patient monitoring category Greybox operates within. It suggests a sizable and expanding commercial backdrop, though the company's success will depend on capturing a specific niche within it.

Partially corroborated -- Market sizing is inferred from analogous third-party reports on the remote patient monitoring sector; specific TAM/SAM for complex chronic care is not publicly available from cited sources.

Competition and Substitutes

Reported and inferred Greybox Solutions operates in a niche defined by the remote coordination of care for patients with complex, chronic conditions, a segment where competition is fragmented between large-scale platform providers and specialized point solutions.

Company	Positioning	Stage / Funding	Notable Differentiator	Source
Greybox Solutions	Digital-health platform for complex chronic care, integrating wearables and clinician-defined analytics.	Seed, ~$852k total funding [PUBLIC]	Focus on clinician-defined rules and Quebec-based deployments for rehabilitation and heart failure.	[Greybox Solutions] [PitchBook, August 2025]

The competitive map in remote patient monitoring (RPM) and chronic care management is stratified. At the top are large, horizontal health IT incumbents like Teladoc and Amwell, which offer broad telehealth suites that can include RPM modules. Their advantage is enterprise-scale distribution and integration with electronic health records, but their offerings are often generalized. The next tier consists of pure-play RPM challengers, such as Biofourmis and Current Health (acquired by Best Buy), which focus on predictive analytics and multi-condition monitoring through proprietary devices and AI. Greybox's segment, complex chronic care coordination, sits adjacent to these players but with a narrower clinical focus, potentially competing with specialized point solutions for conditions like heart failure or COPD.

Greybox's current defensible edge appears to be its early, specific integration into the Quebec healthcare ecosystem. The platform's initial pilot at the Centre hospitalier de l'Université de Montréal (CHUM) and planned extension to other provincial hospitals provides a local beachhead [Greybox.ca, September 2023]. This edge is rooted in regulatory familiarity and clinician relationships, which are durable if the company continues to deliver outcomes and secure provincial contracts. However, it is also perishable; success in Quebec does not automatically translate to other markets with different payer systems and clinical protocols. The company's emphasis on "clinician-defined rules" over purely algorithmic insights is a product differentiator that may foster deeper trust with care teams, but it is a feature that larger competitors could replicate.

The company's most significant exposure is its limited scale and capital runway relative to well-funded competitors. A firm like Biofourmis, backed by significant venture capital, can invest heavily in R&D for its analytics engine and pursue aggressive commercial expansion. Greybox's ~$852,000 in total funding [PitchBook, August 2025] constrains its ability to outspend rivals on sales, marketing, or international clinical validation. Furthermore, the company has not publicly named commercial partners beyond initial pilots, leaving its distribution channel unproven against competitors with established networks of health systems and payer contracts.

The most plausible 18-month scenario is one of regional consolidation versus national scaling. If Greybox successfully converts its Quebec pilots into province-wide standard of care contracts and demonstrates clear reductions in readmissions and costs, it becomes an attractive regional champion and potential acquisition target for a larger platform seeking a foothold in Canada's single-payer market. In this scenario, a 'winner' could be a company like Teladoc looking to bolster its complex care offerings. Conversely, if the company fails to expand beyond its initial pilot sites and its funding remains limited, it becomes a 'loser' to more capitalized specialists like Claris Healthcare, which could use its broader North American footprint to enter the Quebec market with a similar solution, effectively encircling Greybox's niche.

Opportunity

Open sources

If Greybox Solutions can convert its early foothold in Quebec's rehabilitation centers into a standard platform for complex chronic care, it would capture a meaningful share of a multi-billion-dollar operational budget shift from acute to remote care.

The headline opportunity is to become the default remote-care coordination layer for post-acute and chronic disease management in Canada's single-payer system. The company's platform, Takecare, is not merely a patient portal or a data dashboard. It is a clinician-defined rules engine that integrates directly with wearables, aiming to automate monitoring and intervention for conditions like heart failure. This positions it as an operational system for healthcare providers, a category where stickiness is high and switching costs are significant. The evidence that this outcome is reachable, not just aspirational, comes from the platform's reported deployment across "leading rehabilitation centers in Quebec" and a pilot launch at the Centre hospitalier de l'Université de Montréal (CHUM), a major academic hospital [Quantum eMotion, June 2025] [Greybox.ca, September 2023]. These are not hypothetical design partners; they are initial beachheads within the publicly funded system the company aims to serve.

Growth from this beachhead could follow several concrete paths. The most plausible scenarios hinge on systematic expansion within the provincial healthcare framework.

Scenario	What happens	Catalyst	Why it's plausible
Provincial Standard	Quebec's Ministry of Health adopts Takecare as a recommended or funded tool for managing specific high-cost chronic conditions (e.g., heart failure, COPD) across the network.	A successful multi-site pilot results in published clinical outcomes demonstrating reduced readmissions and lower cost of care.	The initial CHUM pilot is structured to be extended to "other hospitals across Quebec," indicating a designed pathway for broader validation [Greybox.ca, September 2023]. Single-payer systems often scale proven tools province-wide.
Pharma Partnership	A pharmaceutical company with a specialty drug for a chronic condition licenses Takecare as a companion diagnostic and adherence platform, bundling it with therapy.	Greybox secures a co-development or commercial agreement with a life sciences partner.	The company's public materials explicitly mention partnerships with "pharmaceutical companies" as part of its ecosystem, suggesting this channel is part of the commercial strategy [Greybox Solutions].

Compounding for Greybox would manifest as a clinical data moat and workflow entrenchment. Each new healthcare institution that adopts the platform contributes patient outcome data from real-world use. This data, processed through the platform's predictive analytics, can refine the clinician-defined rules, making the system more accurate and valuable for the next adopter. Furthermore, integrating the platform into a hospital's or clinic's daily operations creates significant workflow lock-in. Training staff on a new system is costly, and the platform's value increases as it becomes the single source of truth for managing a patient's journey from hospital to home. The company's focus on "clinician-defined rules" is a key part of this flywheel, ensuring the product evolves in lockstep with its users' needs, making it harder for a generic competitor to displace [Greybox Solutions].

The size of the win can be framed by looking at comparable companies in the remote patient monitoring and digital therapeutics space. Publicly traded Teladoc Health, while a much broader telehealth platform, trades at a market cap reflecting the value of managing chronic populations at scale. More directly, the 2021 acquisition of Livongo by Teladoc for $18.5 billion highlighted the premium placed on digital platforms that demonstrably improve outcomes for chronic conditions like diabetes [Teladoc Health, 2021]. While Greybox is earlier and focused on a different clinical niche and geography, the comparable suggests that a platform which becomes essential for managing a high-cost patient cohort can command significant value. If the "Provincial Standard" scenario plays out, Greybox could anchor itself in a system spending tens of billions annually on healthcare, positioning it for a strategic acquisition or a path to standalone scale. This is a scenario-based illustration of potential, not a forecast.

Partially corroborated -- The core opportunity framing relies on confirmed pilot deployments and stated expansion plans. The plausibility of growth scenarios is supported by company statements and the structure of the healthcare market, but specific commercial terms or detailed expansion timelines are not publicly available.

Sources

Open sources

1. [Greybox Solutions, company overview] Greybox Solutions | https://greyboxdev.greybox.ca/en/company/

2. [PitchBook, August 2025] PitchBook company profile | https://pitchbook.com/profiles/company/168643-18

3. [Quantum eMotion, June 2025] Quantum eMotion Expands Strategic Stake in Greybox Solutions to Capitalize on the Digital Therapeutics Surge | https://www.quantumemotion.com/press-release/quantum-emotion-expands-strategic-stake-in-greybox-solutions-to-capitalize-on-the-digital-therapeutics-surge

4. [Greybox.ca, September 2023] Transform management of complex care for patients with heart failure using advanced digital technology | https://greybox.ca/en/blog/2023-09-14-transform-management-of-complex-care-for-patients-with-heart-failure-using-advanced-digital-technology

5. [ensun.io] Top 100 Remote Patient Monitoring Companies in Canada (2025) | https://ensun.io/search/remote-patient-monitoring/canada

6. [Montréal Invivo] Entrepreneurial spotlight videos | https://www.montreal-invivo.com/en/sectors/entrepreneurial-spotlight-videos/

7. [Crunchbase] Greybox Solutions - Crunchbase Company Profile & Funding | https://www.crunchbase.com/organization/greybox-solutions